Researchers attempted to quantify the environmental effects of disposing certain drugs by flushing them down the toilet, and found that this approach poses a negligible eco-toxicological risk.
The prescribing information for several medications has been updated to provide clarification of the opioid-induced constipation indication.
A precautionary recall of Menveo, a meningitis vaccine, was announced by GlaxoSmithKline due to a mechanical intervention.
A closer look into how the danger of malware and viruses, and how you can best prevent such an attack.
Widespread discrimination in healthcare has taken many forms, and violates the most fundamental of human rights. WHO established a goal "to ensure that none is left behind and to read the furthest behind first."
GlaxoSmithKline has made the decision to discontinue manufacturing Ceftin Oral Suspension, a cephalosporin antibacterial drug.
Patients express preference for a pharmacy-driven model of primary care vs a pharmacy offering primary care services.
WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.
If flu vaccines were mandatory for all school-age children, the savings on direct healthcare costs alone would easily reach into the tens of millions.
The FDA has announced a new policy to expedite reviews of generic drug applications in cases where competition is limited.
The American Medical Association is calling for more transparency in drug pricing amid rising costs that are putting some lifesaving medications out of reach for patients and communities.
If the employer's plan is deemed unaffordable, families and individuals now have the ability to purchase insurance at a lower cost through the ACA marketplace.
The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.
On May 4, 2017, the House of Representatives passed the American Health Care Act by a narrow margin, even though the Congressional Budget Office had not officially reviewed and reported on the bill's impact.
A serious shortage of physicians is expected to hit the United States over the next 10 years unless multi-pronged interventions are undertaken.
Hackers are increasingly targeting hospitals, using viruses to lock their computer systems and hold sensitive medical data and other files hostage.
If certain targets are met, the rate of new HIV infections may be down to 12,000 a year by 2025.
Federal standards that mean states will need to deliver care to elderly and disabled Medicaid enrollees in home and community-based settings will take effect in 2022.
Republicans need to reach a challenging consensus on many difficult points if they want to fulfill President Trump's commitment to provide better coverage with more affordable premiums and lower deductibles.
Medical marijuana, as a botanical and a scheduled drug does not fit the FDA paradigm for drug approval, a major impediment to its use in research.
In states where marijuana is legalized for medicinal purposes, Medicare's prescription drug benefit program has lowered its spending due to reduced prescription drug use.
Many believe meds supported by stronger evidence than the law requires to achieve designation.
AAPM will be changing its name to the American Academy of Integrative Pain Management in an effort to emphasize its focus on promoting integrative approaches to pain management.
For practitioners who are interested in implementing an e-prescribing system, Dr Hurford suggests that they seek feedback from colleagues.
For adults with Crohn's, rheumatoid arthritis, or psoriasis.
Reps from physician, hospital, patient safety organizations explore need for national guidelines.
Military Medical School Addresses Opioid Epidemic by Incorporating Joint Pain Education Into CurriculumMarch 30, 2016
The F. Edward Hebert School of Medicine at the USU this week announced the addition of a new pain management program that incorporates joint pain education into its curriculum
One more step to combat the epidemic of opioid abuse.
New labeling rules mostly aimed at immediate-release versions of opioids.
Mainly supportive of guidelines, but concerns include lack of evidence underlying recommendations.
Clinical Pain Advisor Articles
- FDA's Flush List: Assessing the Environmental Impact
- Intrathecal Ziconotide Long-Term Efficacy and Safety for Severe Chronic Pain
- Sciatic Plus Femoral Nerve Blocks Effective on Total Hip Arthroplasty-Related Pain
- Yoga Improves Health Outcomes in Veterans With Chronic Low Back Pain
- Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia
- Uniport vs Multiport Catheters for Labor Epidural Analgesia
- Disease Activity Biomarker in Pediatric SLE
- Guidance on Preventing Medical Billing Errors
- Preemptive Analgesia With Acetaminophen Reduces Headaches Associated With Electroconvulsive Therapy
- Minimum Headache Duration Requiring Subarachnoid Hemorrhage Evaluation